Bayesian Capital Management »

Intellia Therapeutics shares owned by Bayesian Capital Management

Quarter-by-quarter ownership of Intellia Therapeutics (NTLA) shares owned by Bayesian Capital Management from 13F filings

Historical chart of Bayesian Capital Management investment in Intellia Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Intellia Therapeutics held by Bayesian Capital Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Intellia Therapeutics by Bayesian Capital Management

Quarter filed Position value Share count Share price at filing
2024-06-30 $680k 30k 22.38
2024-03-31 $303k 11k 27.51
2023-03-31 $306k 8.2k 37.27
2022-03-31 $301k 4.1k 72.60
2020-03-31 $132k 11k 12.22